The Golden Path Towards Mass Production
Quasar partners with MedNet GmbH, a Germany-based, international service provider for the medical contract manufacturing industry.
inbal
Quasar’s new top-technology production facility
We are happy to announce the opening of our new manufacturing facility in Dongguan, China. The facility is now in the validation phase and will fully operational for mass production during Q1-2018. The new facility is our newest asset in our effort to deliver higher quality and newer technologies for innovative medical device mass production and process-design services. Share With Colleagues [sharethis-inline-buttons]
The Secret Sauce to high quality
The Secret Sauce to high quality: Preventative Quality Processes and Sisyphean Improvement Cycles. Preventive quality processes and Sisyphean Improvement Cycles are the secret sauce to winning your market. Do you have them built into your production process?
QUASAR announces new alliance with MedNet GmbH
Quasar partners with MedNet GmbH, a Germany-based, international service provider for the medical contract manufacturing industry.
Quasar passes ISO 13485 Surveillance with no nonconformities
In Dec 2016, BSI Auditors pored over DHRs, validations and quality objectives; then toured the lines and reviewed procedures during Quasar’s annual audit. We are happy to announce that Quasar was found ISO 13485 compliant, surpassing requirements in every category.
Quasar passes FDA inspection with no 483 findings
An FDA audit was conducted from October 31 to November 3 at the Quasar manufacturing facility in Shenzhen. This is the second consecutive audit Quasar has passed, by the FDA, and the result with NO findings in non-conformance (no 483) endorses Quasar’s renewed commitment to being a qualified medical device manufacturer. Consistent with Quasar’s legacy of maintaining high quality standards, quality is focused on throughout the entire production process, starting from development, and maintained through all phases to manufacturing.
quasar launches new BRANDING
Quasar is pleased to launch its official new BRAND, revealing the company’s strategic change in direction to reflect its focus on the medical device market. Our NEW BRANDING
The Secret of Entering The Automated Assembly Trend
Obamacare and Europe’s economic situation are exerting significant cost pressures on Medical Devices. Leading manufacturers are meeting these pressures with semi and full automation, even at their low-cost locations. The benefits are
QIL expands with larger offices and laboratory
In the first quarter of 2016, QIL, Quasar subsidiary in Israel, expend its offices and laboratory. This expansion is in line with Quasar’s growth and advancement within the medical market.
Quasar targets the medical market for strategic focus
The market for medical devices is growing rapidly, requiring the highly skilled manual assembly of numerous components. This specialized assembly and production necessitates a trusted manufacturing partner.
NPI | New Product Implementation
The product then moves to the new product implementation (NPI) phase.
NPD | New Product Development
Manufacturing excellence begins in the planning stages, even before production commences. The company initiates the first phase, new product development (NPD) process in complete coordination with the customer.